These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2302711

  • 41. Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.
    Carlsen NL, Mortensen BT, Andersson PK, Larsen JK, Nielsen OH, Tommerup N.
    Anticancer Res; 1991; 11(1):353-8. PubMed ID: 2018371
    [Abstract] [Full Text] [Related]

  • 42. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S.
    Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152
    [Abstract] [Full Text] [Related]

  • 43. Modification of myc gene amplification in human somatic cell hybrids.
    Iman DS, Shay JW.
    Cancer Res; 1989 Aug 15; 49(16):4417-22. PubMed ID: 2568170
    [Abstract] [Full Text] [Related]

  • 44. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas.
    Shiloh Y, Korf B, Kohl NE, Sakai K, Brodeur GM, Harris P, Kanda N, Seeger RC, Alt F, Latt SA.
    Cancer Res; 1986 Oct 15; 46(10):5297-301. PubMed ID: 3756879
    [Abstract] [Full Text] [Related]

  • 45. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE, Tai KF, Smith RS, Dillon PA, Brodeur GM, Carroll WL.
    Oncogene; 1997 Oct 16; 15(16):1937-46. PubMed ID: 9365240
    [Abstract] [Full Text] [Related]

  • 46. Biological characteristics of N-myc amplified neuroblastoma in patients over one year of age.
    Nakagawara A, Ikeda K, Tsuda T, Higashi K.
    Prog Clin Biol Res; 1988 Oct 16; 271():31-9. PubMed ID: 3406005
    [Abstract] [Full Text] [Related]

  • 47. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP.
    Clin Cancer Res; 2000 May 16; 6(5):1900-8. PubMed ID: 10815914
    [Abstract] [Full Text] [Related]

  • 48. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitroulakos J, Yeger H, Ling V.
    Clin Cancer Res; 1997 Oct 16; 3(10):1699-706. PubMed ID: 9815553
    [Abstract] [Full Text] [Related]

  • 49. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 50. Amplification of N-myc in a rhabdomyosarcoma.
    Mitani K, Kurosawa H, Suzuki A, Hayashi Y, Hanada R, Yamamoto K, Komatsu A, Kobayashi N, Nakagome Y, Yamada M.
    Jpn J Cancer Res; 1986 Nov 01; 77(11):1062-5. PubMed ID: 2432051
    [Abstract] [Full Text] [Related]

  • 51. N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma.
    Hossain MS, Ozaki T, Wang H, Nakagawa A, Takenobu H, Ohira M, Kamijo T, Nakagawara A.
    Oncogene; 2008 Oct 09; 27(46):6075-82. PubMed ID: 18591937
    [Abstract] [Full Text] [Related]

  • 52. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R, Carroll WL.
    Cancer; 2003 Aug 15; 98(4):841-53. PubMed ID: 12910530
    [Abstract] [Full Text] [Related]

  • 53. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG, Schafer R, Willecke K, Pluzhnikova GF, Serova OM.
    Mol Biol (Mosk); 1986 Aug 15; 20(5):1236-43. PubMed ID: 3022123
    [Abstract] [Full Text] [Related]

  • 54. Increased expression of the proto-oncogene, c-myc, in human neuroblastoma cells by reversible inhibition of cell growth.
    Fukuchi K, Tomoyasu S, Watanabe K, Suzuki H, Kaetsu T, Takagi Y, Tsuruoka N, Gomi K.
    Anticancer Res; 1991 Aug 15; 11(6):1967-73. PubMed ID: 1776829
    [Abstract] [Full Text] [Related]

  • 55. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
    Hiyama E, Hiyama K, Yokoyama T.
    Cancer Res; 1991 Apr 01; 51(7):1946-51. PubMed ID: 2004381
    [Abstract] [Full Text] [Related]

  • 56. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
    Brack T, Scholz RB, Milde-Langosch K, Heinsohn S, Löning T, Kabisch H.
    Cancer Detect Prev; 1992 Apr 01; 16(3):185-92. PubMed ID: 1458508
    [Abstract] [Full Text] [Related]

  • 57. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
    Hasan Z, Inoue A, Ikeda H, Kamii Y, Obana K, Yokomori K, Tsuchida Y, Hemmi H, Shimatake H.
    Eur J Pediatr Surg; 1999 Jun 01; 9(3):138-41. PubMed ID: 10427487
    [Abstract] [Full Text] [Related]

  • 58. Beta 2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation.
    Cooper MJ, Hutchins GM, Mennie RJ, Israel MA.
    Cancer Res; 1990 Jun 15; 50(12):3694-700. PubMed ID: 2187600
    [Abstract] [Full Text] [Related]

  • 59. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
    Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM.
    Science; 1984 Jun 08; 224(4653):1121-4. PubMed ID: 6719137
    [Abstract] [Full Text] [Related]

  • 60. Neuroblastoma: inhibition of progression (Part II). Basic science in pediatric surgery.
    Girgert R, Wittrock J, Schweizer P.
    Eur J Pediatr Surg; 2001 Dec 08; 11(6):363-7. PubMed ID: 11807663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.